Fermi Inc. heads into October with short sellers accelerating their bets against a stock already down 17% on the week, while an activist on the register and a deeply discounted price tag relative to analyst targets frame a story of genuine two-sided tension.
The short positioning is the sharpest signal right now. Short interest has climbed nearly 48% over the past month, reaching 12% of the free float. That is a sustained and deliberate build, not noise. The pace has quickened this week, with the float-adjusted position rising another 3.6% over the past seven days. The ORTEX short score has moved consistently higher, sitting at 70.9 on September 29 against a reading of 68.8 just two weeks ago. Factor scores paint the same picture, with the short score ranking in the 4th percentile of the universe, meaning almost every stock is less shorted on a relative basis.
The borrow market tells a more nuanced story than the headline short build suggests. Availability has tightened from over 250% of short interest in mid-August to 39% now, meaning there are fewer than four shares available to borrow for every ten already on loan. Cost to borrow has risen 37% over the week to 0.83%, up from 0.24% in early September. That is still an absolute level that creates no meaningful friction for new shorts. The 52-week minimum availability hit 0.19%, so the current tightness is notable but not yet at the extreme the lending market has seen. Options positioning is calm: the put/call ratio of 0.41 is barely above its 20-day average of 0.40, telling a different story to the short book, call buyers are not running for cover.
The Street has spent the past several months slashing targets with no sign of a floor. Mizuho cut its target from $27 to $11 in late July while holding an Outperform rating, a striking gap between direction and conviction. Macquarie followed in mid-August, trimming from $18 to $15, still with an Outperform. The consensus mean target of $17.50 against a closing price of $4.28 implies more than 300% upside on paper, but these targets have been in freefall and the most recent cuts date from mid-August, making the gap an artifact of stale numbers rather than a credible signal. The analyst data is 47 days old. The bull case centres on Fermi's behind-the-meter power platform for AI workloads: the 17 GW private grid vision, Project Matador, and a leadership bench with cited 25 GW of combined experience. The bear case is blunter: the business is pre-revenue in any meaningful sense, EBITDA estimates have been pushed deep into 2027 and 2028, the prior CEO departed abruptly with an after-hours share drop of roughly 31%, and execution depends on regulatory approvals and lease-up that remain speculative.
Ownership and insider activity add colour to the activist dimension. Caddis Holdings filed a Schedule 13D on the EDGAR register, making it an activist of record with an 8.2% stake. A 13D filing signals a holder with stated intent to influence the direction of the company. Caddis first appeared in May 2026 and has filed four times. Toby Neugebauer filed a passive 13G in November 2025 covering a 24.1% stake, though the current institutional register shows his holding at around 1.8% of shares, well below the original filing level. Stakes are as last disclosed around the 5% threshold, and a holder dropping below that level may not file again, so the picture is incomplete. On insiders, the net position over the past 90 days is negative at approximately $7.3 million sold. The most recent open-market sale was director James Perry, who sold 863,637 shares at $7.31 in late June. The CEO, Lee McIntire, received 468,750 shares as a grant in mid-August following his August 11 appointment. These are compensation mechanics rather than conviction purchases. The Wikipedia attention z-score for FRMI registered 2.2 as of September 23, placing retail interest well above the stock's own recent baseline, though retail attention is not a revenue indicator.
Prior earnings reactions give some grounding to the volatility picture. The two most recent prints both produced first-day declines of roughly 7% and 16% respectively, with five-day moves of negative 10% and negative 21%. The next scheduled earnings date is November 13. With short interest near the month's high, availability tightening fast, and borrowing costs rising, what matters most between now and that print is whether any of the prospective hyperscaler or neocloud agreements that management has flagged move from indication to definitive contract, because that is the fact the market has been waiting for since the original $150 million construction advance was cancelled.
See the live data behind this article on ORTEX.
Open FRMI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
